Gyre Therapeutics, Inc.
Sales Per Share
| Fiscal Year | Sales Per Share |
|---|---|
| FY2009 | $0.49 |
| FY2010 | $1.42 |
| FY2011 | $1.54 |
| FY2012 | $0.86 |
| FY2013 | $0.05 |
| FY2014 | $0.37 |
| FY2017 | $0.08 |
| FY2018 | $0.00 |
| FY2020 | $0.47 |
| FY2021 | $0.12 |
| FY2022 | $1.35 |
| FY2023 | $1.72 |
| FY2024 | $1.03 |
| FY2025 | $1.13 |
Sales Per Share
| Fiscal Year | Sales Per Share |
|---|---|
| FY2009 | $0.49 |
| FY2010 | $1.42 |
| FY2011 | $1.54 |
| FY2012 | $0.86 |
| FY2013 | $0.05 |
| FY2014 | $0.37 |
| FY2017 | $0.08 |
| FY2018 | $0.00 |
| FY2020 | $0.47 |
| FY2021 | $0.12 |
| FY2022 | $1.35 |
| FY2023 | $1.72 |
| FY2024 | $1.03 |
| FY2025 | $1.13 |